4-Octyl-N-phenylaniline

Catalog No.: 
ACJLRX104
CAS No.: 
4175-37-5
Molecular Formula: 
C20H27N
Molecular Weight: 
281.44
4-Octyl-N-phenylaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$214.00InquiryInquiry
250mg95%$355.00InquiryInquiry
1g95%$884.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Octyl-N-phenylaniline
IUPAC Name4-octyl-N-phenylaniline
Molecular FormulaC20H27N
Molecular Weight281.44
SMILESCCCCCCCCC1=CC=C(C=C1)NC2=CC=CC=C2
InChI KeyDMLLDZGHGNLZNW-UHFFFAOYSA-N
Synonym4-octyl-N-phenylaniline;Benzenamine, 4-octyl-N-phenyl-;4-OCTYLDIPHENYLAMINE;4-OCTYL-N-PHENYLBENZENAMIDE;4-octyl-n-phenyl-benzenamin;4-Octylphenylphenylamine;4-octyl-N-phenylaniline 4175-37-5
CAS No.4175-37-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H303-H315-H319-H335-H413
Precautionary Statement(s)
P261-P264-P271-P273-P280-P304+P340+P312-P305+P351+P338-P312-P332+P313-P337+P313-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACJLRX104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSXKJ741 route compound structure diagram
    ACSXKJ74116245-79-7In Stock
  4. Then
  5. ACJLRX104 route product structure diagram
    ACJLRX1044175-37-5
Inquiry

2. ACJLRX104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCABX964 route compound structure diagram
    ACCABX96451554-93-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJLRX104 route product structure diagram
    ACJLRX1044175-37-5
Inquiry

3. ACJLRX104 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJLRX104 route product structure diagram
    ACJLRX1044175-37-5
Inquiry

Comments (0)